Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: A case report

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background: Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15-20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations have not been studied extensively. Case presentation: The current study reports a patient presenting with rapidly growing DDLPS accompanied by multiple lung and pleural metastases, in whom whole-exome sequencing revealed a NF1 truncating mutation of the known pathogenic variant, c.C7486T, p.R2496X, as well as multiple copy number alterations (CNAs), including the well-known 12q13-15 amplification, and multiple chromothripsis events encompassing potential cancer-related genes. Conclusions: Our results suggest that, in addition to the 12q13-15 amplification, NF1 inactivation mutation and other CNAs may contribute to DDLPS tumorigenesis accompanied by aggressive clinical features.

Original languageEnglish
Article number200
JournalBMC Medical Genetics
Volume21
Issue number1
DOIs
StatePublished - 12 Oct 2020

Bibliographical note

Publisher Copyright:
© 2020 The Author(s).

Keywords

  • Case report
  • Copy number alteration
  • Copy number alternation
  • Liposarcoma
  • Mutation
  • NF1

Fingerprint

Dive into the research topics of 'Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: A case report'. Together they form a unique fingerprint.

Cite this